机构:[1]Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China江苏省人民医院[2]Department of Ophthalmology, the Second People’s Hospital of Yunnan Province (Fourth Affiliated Hospital of Kunming Medical University), Yunnan Eye Institute, Key Laboratory of Yunnan Province for the Prevention and Treatment of Ophthalmology (2017DG008), Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People’s Hospital of Yunnan Province (2017HC010), Expert Workstation of Yao Ke (2017IC064), Kunming, China[3]Shenzhen University School of Medicine, Shenzhen Eye Hospital, Shenzhen, China[4]Tissue Tech, Inc., Ocular Surface Center, Ocular Surface Research & Education Foundation, Miami, Florida
Trabecular meshwork (TM) contains a subset of adult stem cells or progenitors that can be differentiated into corneal endothelial cells, adipocytes and chondrocytes, but not osteocytes or keratocytes. Accordingly, these progenitors can be utilized as a cell-based therapy to prevent blindness caused by glaucoma, corneal endothelial dysfunction and other diseases in general. In this review, we review in vitro expansion techniques for TM progenitors, discuss their phenotypic properties, and highlight their potential clinical applications in various ophthalmic diseases.
基金:
Natural Science Fund of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2015A030313774]
第一作者机构:[1]Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
共同第一作者:
通讯作者:
通讯机构:[4]Tissue Tech, Inc., Ocular Surface Center, Ocular Surface Research & Education Foundation, Miami, Florida[*1]Research and Development Department, TissueTech, Inc., Miami, FL
推荐引用方式(GB/T 7714):
Hong Sun,Qin Zhu,Ping Guo,et al.Trabecular meshwork cells are a valuable resource for cellular therapy of glaucoma[J].JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.2019,23(3):1678-1686.doi:10.1111/jcmm.14158.
APA:
Hong Sun,Qin Zhu,Ping Guo,Yuan Zhang,Sean Tighe&Yingting Zhu.(2019).Trabecular meshwork cells are a valuable resource for cellular therapy of glaucoma.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,23,(3)
MLA:
Hong Sun,et al."Trabecular meshwork cells are a valuable resource for cellular therapy of glaucoma".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 23..3(2019):1678-1686